The study aimed to evaluate the association between retinopathy of prematurity (ROP) and hearing loss in preterm infants.
Clinicians caring for preterm infants who required ROP treatment should be aware of a potential association with hearing loss, supporting thorough audiology follow-up screening in this population; however, the retrospective design limits causal conclusions.
Identifying co-occurrence of ROP treatment and hearing loss in preterm infants could help prioritize high-risk neonates for early audiology screening and multidisciplinary follow-up.
- 01Retrospective design examining hearing loss rates in preterm infants who needed ROP treatment.
- 02Both ROP and hearing loss share common risk factors in prematurity (e.g., low gestational age, NICU interventions).
- 03Findings may support integrated screening protocols for preterm infants with severe ROP.
- 04Published in American Journal of Otolaryngology (2026).
- 05Causal direction cannot be established from a retrospective study.
Treatment-requiring retinopathy of prematurity is associated with hearing loss in preterm infants.
studypartially supported- PMID
- 42208094
- DOI
- 10.1016/j.amjoto.2026.104861.
- Journal
- American Journal of Otolaryngology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Preterm infants with treatment-requiring retinopathy of prematurity
- Intervention
- Presence of treatment-requiring retinopathy of prematurity
- Comparator
- Preterm infants without treatment-requiring ROP
Primary outcomes
Prevalence/association of hearing loss in preterm infants with treatment-requiring ROP